Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 15;131(4):e143771.
doi: 10.1172/JCI143771.

Gastrointestinal motility disorders in neurologic disease

Review

Gastrointestinal motility disorders in neurologic disease

Michael Camilleri. J Clin Invest. .

Abstract

The extrinsic and autonomic nervous system intricately controls the major functions of the gastrointestinal tract through the enteric nervous system; these include motor, secretory, sensory, storage, and excretory functions. Disorders of the nervous system affecting gastrointestinal tract function manifest primarily as abnormalities in motor (rather than secretory) functions. Common gastrointestinal symptoms in neurologic disorders include sialorrhea, dysphagia, gastroparesis, intestinal pseudo-obstruction, constipation, diarrhea, and fecal incontinence. Diseases of the entire neural axis ranging from the cerebral hemispheres to the peripheral autonomic nerves can result in gastrointestinal motility disorders. The most common neurologic diseases affecting gastrointestinal function are stroke, parkinsonism, multiple sclerosis, and diabetic neuropathy. Diagnosis involves identification of the neurologic disease and its distribution, and documentation of segmental gut dysfunction, typically using noninvasive imaging, transit measurements, or intraluminal measurements of pressure activity and coordination of motility. Apart from treatment of the underlying neurologic disease, management focuses on restoration of normal hydration and nutrition and pharmacologic treatment of the gut neuromuscular disorder.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: MC owns equity in Enterin Inc., which is developing ENT-01 for Parkinson disease. In the past year, MC has received research grants from Allergan (eluxadoline for bile acid diarrhea), Takeda (TAK-954 for gastroparesis), and ILSI North America (intestinal permeability). MC has submitted patent applications for (a) capsule for colonic transit by scintigraphy (publication number US5827497A); (b) 13C-mannitol for permeability measurements (publication number US20190145953); and (c) obesity-metabolomics to identify different phenotypes (publication number WO2019104146A1).

Figures

Figure 1
Figure 1. Control of gut motility: extrinsic autonomic neural control, enteric nervous system, and smooth muscle function.
The left panel shows extrinsic neural control, including the vagus and sacral parasympathetic nerves (blue) and the sympathetic innervation (red) originating from levels thoracic 5 to lumbar 2 in the spinal cord. The right panel shows the organization of the enteric nervous system, which demonstrates plexuses in the submucosal and intermuscular layers called the submucosal plexus and myenteric plexus. In addition, there are pacemakers in the wall of the intestine, including the interstitial cells of Cajal (ICCs) and fibroblast-like cells bearing receptors for PDGFRα, which convey the neural stimulus to the smooth muscle cells. These pacemaker cells and plexuses help to coordinate muscular and secretory functions of the digestive tract.
Figure 2
Figure 2. Components of the peristaltic reflex and relationship to enteric and extrinsic neural control.
In the peristaltic reflex, distension of the intestine by a bolus is sensed by the intrinsic primary afferent neurons, which stimulate interneurons to activate ascending contraction proximal to the bolus through excitatory neurons. Stimulation of muscles occurs through effects of transmitters such as acetyl choline and neurokinins such as substance P and substance K. The intrinsic primary afferent neuron also stimulates descending inhibition in the receiving segment of the intestine distal to the bolus, and this effect is mediated by inhibitory transmitters, such as VIP and nitric oxide (NO).
Figure 3
Figure 3. Neurologic disorders known to affect gastrointestinal motility.
These disease processes involve craniosacral parasympathetic pathways (left), sympathetic pathways (middle), and/or primary enteric nerves or smooth muscle (right). ENS, enteric nervous system.

References

    1. Kreulen DL, Szurszewski JH. Reflex pathways in the abdominal prevertebral ganglia: evidence for a colo-colonic inhibitory reflex. J Physiol. 1979;295:21–32. doi: 10.1113/jphysiol.1979.sp012952. - DOI - PMC - PubMed
    1. Langley JN, Anderson HK. On the innervation of the pelvic and adjoining viscera: Part I. The lower portion of the intestine. J Physiol. 1895;18(1–2):67–105. - PMC - PubMed
    1. Szurszewski JH, Krier J. Sympathetic regulation of gastrointestinal motility. In: Dyck PJ, et al., eds. Peripheral Neuropathy. 2nd ed. WB Saunders; 1984:265–284.
    1. Camilleri, M. Autonomic regulation of gastrointestinal motility. In: Low PA, ed. Clinical Autonomic Disorders: Evaluation and Management. 2nd ed. Lippincott-Raven Publishers; 1997:135–145.
    1. Camilleri M, et al. Gastroparesis. Nat Rev Dis Primers. 2018;4(1):41. doi: 10.1038/s41572-018-0038-z. - DOI - PubMed

Publication types

MeSH terms